Showing results 1 to 20 of 98
next >
| Issue Date | Title | Author(s) |
| 2005-01-01 | Alternatives to for-profit corporatisation: The view from general practice | Anderson, R; Haywood, P; Usherwood, T; Haas, M; Hall, J |
| 2013-12-01 | Are the true impacts of adverse events considered in economic models of antineoplastic drugs? a systematic review | Pearce, A; Haas, M; Viney, R |
| 2005-03-08 | Assessing the capacity of the health services research community in Australia and New Zealand | Pirkis, J; Goldfeld, S; Peacock, S; Dodson, S; Haas, M; Cumming, J; Hall, J; Boulton, AF |
| 2012-05-29 | Breaking up is hard to do: Why disinvestment in medical technology is harder than investment | Haas, M; Hall, J; Viney, R; Gallego, G |
| 2009-01-01 | Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial | Chenoweth, L; King, MT; Jeon, YH; Brodaty, H; Stein-Parbury, J; Norman, R; Haas, M; Luscombe, G |
| 2012-11-22 | Chemotherapy administration: Modelling the costs of alternative protocols | Haywood, P; De Raad, J; Van Gool, K; Haas, M; Gallego, G; Pearson, SA; Faedo, M; Ward, R |
| 2021-11 | Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences. | Yu, A; Street, D; Viney, R; Goodall, S; Pearce, A; Haywood, P; Haas, M; Battaglini, E; Goldstein, D; Timmins, H; Park, SB |
| 2015 | Complexity and doctor choices when discussing contraceptives | Fiebig, D; Viney, RC; Haas, M; Knox, S; Street, D; Weisberg, E; Bateson, D |
| 2017-01-01 | Consideration Sets and Their Role in Modelling Doctor Recommendations About Contraceptives | Fiebig, DG; Viney, R; Knox, S; Haas, M; Street, DJ; Hole, AR; Weisberg, E; Bateson, D |
| 2008-01-01 | Cost and utilisation of healthcare resources during rehabilitation after ankle fracture are not linked to health insurance, income, gender, or pain: An observational study | Lin, CWC; Haas, M; Moseley, AM; Herbert, RD; Refshauge, KM |
| 2004-02-01 | Cost-effectiveness analysis of the New South Wales adult drug court program | Shanahan, M; Lancsar, E; Haas, M; Lind, B; Weatherburn, D; Chen, S |
| 2021-12 | Cost-effectiveness of a complex intervention in general practice to increase uptake of long-acting reversible contraceptives in Australia. | Lewandowska, M; De Abreu Lourenco, R; Haas, M; Watson, CJ; Black, KI; Taft, A; Lucke, J; McGeechan, K; McNamee, K; Peipert, JF; Mazza, D |
| 2008-02-01 | The cost-effectiveness of cervical screening in Australia: What is the impact of screening at different intervals or over a different age range? | Anderson, R; Haas, M; Shanahan, M |
| 2012-06-01 | The cost-effectiveness of falls prevention interventions for older community-dwelling Australians | Church, J; Goodall, S; Norman, R; Haas, M |
| 2011-07-01 | Cost-effectiveness of general practice care for low back pain: A systematic review | Lin, CWC; Haas, M; Maher, CG; MacHado, LAC; Van Tulder, MW |
| 2011-07-01 | Cost-effectiveness of guideline-endorsed treatments for low back pain: A systematic review | Lin, CWC; Haas, M; Maher, CG; MacHado, LAC; Van Tulder, MW |
| 2014-11-01 | COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCER | Hou, C; Siva, S; Haas, M; Viney, R |
| 2022-12-01 | Cost-Effectiveness of Single Versus Multifraction SABR for Pulmonary Oligometastases: The SAFRON II Trial. | Lourenco, RDA; Khoo, T; Crothers, A; Haas, M; Montgomery, R; Ball, D; Bressel, M; Siva, S |
| 2009-05-01 | Decisions about Pap tests: What influences women and providers? | Fiebig, DG; Haas, M; Hossain, I; Street, DJ; Viney, R |
| 2012-12-01 | Delays in access to affordable medicines: Putting policy into perspective | Pearce, A; Van Gool, K; Haywood, P; Haas, M |
